Current Infectious Disease Reports

, Volume 11, Issue 3, pp 173–174 | Cite as

Extensively drug-resistant tuberculosis: Lessons from the US experience

  • Janet R. Maurer
Clinical Trials Report


  1. 1.
    World Health Organization: Anti-tuberculosis drug resistance in the world: fourth global report. Available at Accessed November 2008.
  2. 2.
    Centers for Disease Control and Prevention: Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs—worldwide, 2000–2004. MMWR Morb Mortal Wkly Rep 2006, 55: 301–305.Google Scholar
  3. 3.
    Wells CD, Cegielski JP, Nelson LJ, et al.: HIV infection and multidrug-resistant tuberculosis—the perfect storm. J Infect Dis 2007, 196: S86–S107.PubMedCrossRefGoogle Scholar
  4. 4.
    Revised definition of extensively drug-resistant tuberculosis. MMWR Morb Mortal Wkly Rep 2006, 55(43): 1176.Google Scholar
  5. 5.
    Kim HR, Hwang SS, Kim HJ, et al.: Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis. Clin Infect Dis 2007, 45: 1290–1296.PubMedCrossRefGoogle Scholar
  6. 6.
    Gandhi NR, Moll A, Sturm AW, et al.: Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006, 368: 1575–1580.PubMedCrossRefGoogle Scholar
  7. 7.
    Mitnick CD, Shin SS, Seung KJ, et al.: Comprehensive treatment of extensively drug-resistant tuberculosis. N Engl J Med 2008, 359: 563–574.PubMedCrossRefGoogle Scholar

Copyright information

© Current Medicine Group, LLC 2009

Authors and Affiliations

  • Janet R. Maurer

There are no affiliations available

Personalised recommendations